Concepedia

Author

G. Vignir Helgason

University of GlasgowORCID

Also Known As

G V Helgason, G Vignir Helgason, G. V. Helgason, G. Vignir Helgason, G.Vignir Helgason, Gudmundur Helgason, Gudmundur V Helgason, Gudmundur V. Helgason, Gudmundur Vignir Helgason, Gudmundur Vignir  Helgason

73

Publications

16K

Citations

27

H-Index

43

Concepts

All Affiliations

University of GlasgowCancer Research UK Scotland InstituteCancer Research UKThomas Jefferson UniversitySidney Kimmel Cancer Center
GV

About

G. Vignir Helgason is an author at University of Glasgow specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

5.5K

2

Engineering

1

1

65

3

Health Sciences

1

1

543

4

Natural Sciences

1

1

4K

5

Allergy

1

1

4K

G. Vignir Helgason

×

22

Publications

14.8K

Citations

20

H-Index

YearCitations

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe,

Autophagy

2016

5.9K

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich,

Autophagy

2012

4K

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>

Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah,

Autophagy

2021

2.5K

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton,

Journal of Clinical Investigation

2009

556

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Elodie M. Kuntz, Pablo Baquero, Alison M. Michie,

Nature Medicine

2017

543

Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival

Ashley Hamilton, G. Vignir Helgason, Mirle Schemionek,

Blood

2011

421

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition

Rebecca Mitchell, Lisa Hopcroft, Pablo Baquero,

JNCI Journal of the National Cancer Institute

2017

130

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors

Pablo Baquero, Amy Dawson, Arunima Mukhopadhyay,

Leukemia

2018

114

ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells

Maria Karvela, Pablo Baquero, Elodie M. Kuntz,

Autophagy

2016

108

The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors

Francesca Pellicano, Mary T. Scott, G. Vignir Helgason,

Stem Cells

2014

89

Page 1